LPL Financial’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
101,449
+27,220
| +37% | +$591K | ﹤0.01% | 3017 |
|
|
2025
Q1 | $1.8M | Buy |
74,229
+16,246
| +28% | +$394K | ﹤0.01% | 3020 |
|
|
2024
Q4 | $1.21M | Buy |
57,983
+15,961
| +38% | +$333K | ﹤0.01% | 3307 |
|
|
2024
Q3 | $835K | Buy |
42,022
+2,558
| +6% | +$50.9K | ﹤0.01% | 3508 |
|
|
2024
Q2 | $611K | Sell |
39,464
-22,073
| -36% | -$342K | ﹤0.01% | 3640 |
|
|
2024
Q1 | $981K | Sell |
61,537
-8,986
| -13% | -$143K | ﹤0.01% | 3164 |
|
|
2023
Q4 | $1.19M | Sell |
70,523
-15,649
| -18% | -$263K | ﹤0.01% | 2873 |
|
|
2023
Q3 | $1.01M | Buy |
86,172
+52,294
| +154% | +$611K | ﹤0.01% | 2862 |
|
|
2023
Q2 | $455K | Sell |
33,878
-33,334
| -50% | -$448K | ﹤0.01% | 3489 |
|
|
2023
Q1 | $1.11M | Buy |
67,212
+14,646
| +28% | +$243K | ﹤0.01% | 2665 |
|
|
2022
Q4 | $978K | Buy |
52,566
+28,159
| +115% | +$524K | ﹤0.01% | 2658 |
|
|
2022
Q3 | $313K | Buy |
24,407
+1,431
| +6% | +$18.4K | ﹤0.01% | 3521 |
|
|
2022
Q2 | $161K | Buy |
22,976
+4,210
| +22% | +$29.5K | ﹤0.01% | 3979 |
|
|
2022
Q1 | $156K | Buy |
18,766
+3,128
| +20% | +$26K | ﹤0.01% | 3870 |
|
|
2021
Q4 | $106K | Sell |
15,638
-4,435
| -22% | -$30.1K | ﹤0.01% | 4115 |
|
|
2021
Q3 | $106K | Buy |
+20,073
| New | +$106K | ﹤0.01% | 4100 |
|
|
2020
Q4 | – | Sell |
-10,000
| Closed | -$30K | – | 3798 |
|
|
2020
Q3 | $30K | Buy |
+10,000
| New | +$30K | ﹤0.01% | 3456 |
|